Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;12(9):855-8.
doi: 10.1111/j.1442-2042.2005.01158.x.

Clinical study of six cases showing late relapse of germ cell tumors

Affiliations

Clinical study of six cases showing late relapse of germ cell tumors

Mototsugu Muramaki et al. Int J Urol. 2005 Sep.

Abstract

Late relapse of germ cell tumors has been considered rare. We report six patients treated at our institution with relapses of germ cell tumors more than 2 years after first successful management. Median time to late relapse for pure seminomas and non-seminomatous germ cell tumors was 30.0 and 75.5 months, respectively. The sites of the late relapses in two cases of pure seminoma were located out of the fields of irradiation. After systematic chemotherapy, both these patients remain disease free. Two patients with non-seminomatous germ cell tumors received salvage chemotherapy at the time of late relapse, but tumor markers did not normalize in either case. A complete resection of relapsed masses was performed in three cases of non-seminomatous germ cell tumors. All three patients are without evidence of disease. The incidence of late relapse in patients with pure seminomas and non-seminomas was 2.4% and 3.3%, respectively, which suggests the necessity for long-term follow up.

PubMed Disclaimer

Similar articles

Cited by

  • Late relapse of testis cancer.
    Ehrlich Y, Rosenbaum E, Baniel J. Ehrlich Y, et al. Curr Urol Rep. 2013 Oct;14(5):518-24. doi: 10.1007/s11934-013-0355-4. Curr Urol Rep. 2013. PMID: 23839244 Review.
  • Late recurrence and salvage therapy of CNS germinomas.
    Kamoshima Y, Sawamura Y, Ikeda J, Shirato H, Aoyama H. Kamoshima Y, et al. J Neurooncol. 2008 Nov;90(2):205-11. doi: 10.1007/s11060-008-9649-7. Epub 2008 Jul 5. J Neurooncol. 2008. PMID: 18604473

LinkOut - more resources